Follow SLLSA
Salt Lake Life Sciences Angels on LinkedIn Salt Lake Life Science Angels on Blogger Follow SLLSAngels on Twitter Follow SLLSAngels on Facebook Salt Lake Life Science Angels on RSS
       HOME     PORTFOLIO     SUBMIT YOUR PLAN     MANAGEMENT     SPONSORS     NEWS     MEETINGS     CONTACT US     BLOG    

SEEKING INVESTMENT?


SLLSA MEMBERS:


FOUNDING SPONSORS:






SPONSORS:






MANAGEMENT - Board of Directors

Andrew Laver

Mr. Laver is currently the Managing Director of APL Capital Advisors (www.APLcapital.com). Prior to founding APL Capital, Andrew gained investment and transactional experience in the venture capital and private equity industries. Andrew also has an operations and technical background having worked as an engineering project manager at the Abbott Laboratories Hospital Products Division and as a research assistant at the University of Utah. He holds Series 7, 63, & 79 securities licenses. Andrew has a MBA (with distinction) from New York University, and a MS in Bioengineering from the University of Utah. He also holds bachelor’s degrees (cum laude) in Electrical Engineering and Asian Studies from the University of Utah.


Ted Stanley, MD

Dr. Stanley is currently the Chairman & Founder of Zars Pharma (www.Zars.com) and a Professor of Anesthesiology at the University of Utah. Dr. Stanley graduated from Columbia College and then Columbia University Medical School before completing a residency in anesthesiology at the Columbia-Presbyterian Medical Center. Dr. Stanley was director of research at the University of Utah for over 20 years and is internationally known for his developmental work on opioids, other intravenous anesthetics and novel drug delivery techniques. In 1985, he co-founded Anesta, a drug delivery company with two FDA-approved products: fentanyl Oralet and Actiq.


Kevin Herrmann

Mr. Herrmann is currently the Founder & CEO of 3PointData (www.3PointData.com), a new company providing businesses with the critical data they need to make better decisions. Previously, Mr. Herrmann founded and was CEO of Enigma Medical Systems, a medical records software company that he later sold to Henry Schein. After the sale, Mr. Herrmann remained at Henry Schein for several years working in strategic and new product development. Kevin began his career with Accenture and has extensive experience in innovation and product development, user experience design and business process improvement. Mr. Herrmann has a bachelor’s degree in Computer Science from Southern Illinois University.